University of California, Los Angeles About Us   |   Diversity and Inclusion  |   Contact Us   |   Campus Directory   |   Giving   |   Maps/Directions

Brad Spellberg, M.D.

Contact Information:

Work Phone Number:

(310) 222-5381
(310) 781-3680
(310) 782-2016

Mailing Address:

1124 West Carson Street
Torrance, CA 90502
UNITED STATES

Work Email Address:

bspellberg@labiomed.org

Associate Professor, Medicine

Member, CTSI


Publications:

Luo Guanpingsheng, Spellberg Brad, Gebremariam Teclegiorgis, Bolaris Michael, Lee Hongkyu, Fu Yue, French Samuel W, Ibrahim Ashraf S   Diabetic murine models for Acinetobacter baumannii infection. The Journal of antimicrobial chemotherapy, 2012; 67(6): 1439-45.
Baquir Beverlie, Lemaire Sandrine, Van Bambeke Françoise, Tulkens Paul M, Lin Lin, Spellberg Brad   Macrophage killing of bacterial and fungal pathogens is not inhibited by intense intracellular accumulation of the lipoglycopeptide antibiotic oritavancin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012; 54 Suppl 3(6): S229-32.
Spellberg Brad, Daum Robert   Development of a vaccine against Staphylococcus aureus. Seminars in immunopathology, 2012; 34(2): 335-48.
Spellberg Brad, Kontoyiannis Dimitrios P, Fredricks David, Morris Michele I, Perfect John R, Chin-Hong Peter V, Ibrahim Ashraf S, Brass Eric P   Risk factors for mortality in patients with mucormycosis. Medical mycology : official publication of the International Society for Human and Animal Mycology, 2012; 54 Suppl 3(6): .
Spellberg Brad, Ibrahim Ashraf S, Chin-Hong Peter V, Kontoyiannis Dimitrios P, Morris Michele I, Perfect John R, Fredricks David, Brass Eric P   The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. The Journal of antimicrobial chemotherapy, 2012; 67(3): 715-22.
UCLA    |    Terms & Conditions    |    Disability Resources    |    UC Regents